Why the study?
Are mean platelet volume, platelet distribution width, and platelet count altered in subjects with T2DM, IFG, IGT, or metabolic syndrome compared to controls?
Population
Subjects with type 2 diabetes mellitus, impaired fasting glucose, impaired glucose tolerance, or metabolic…
Design
Meta-analysis
Authors
Loading...
Elevated MPV may flag heightened thrombotic risk in T2DM and IFG; extends meta-analytic support for platelet changes across the glycemic spectrum.
Are mean platelet volume, platelet distribution width, and platelet count altered in subjects with T2DM, IFG, IGT, or metabolic syndrome compared to controls?
Subjects with T2DM and IFG have higher mean platelet volume and platelet distribution width compared to controls, suggesting a potential link to cardiovascular disease risk.
Zaccardi et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: